Inactive Instrument
Capstone Therapeutics Corp Share Price Other OTC
Stocks
US14068E1091
Construction Materials
| Market Cap | 31.69L 27.75L 25.62L 23.92L 45.03L 30Cr 46.06L 3.08Cr 1.19Cr 15Cr 1.19Cr 1.16Cr 51Cr | P/E 2026 * |
4.18x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 31.69L 27.75L 25.62L 23.92L 45.03L 30Cr 46.06L 3.08Cr 1.19Cr 15Cr 1.19Cr 1.16Cr 51Cr | EV / Sales 2026 * |
0.04x | EV / Sales 2027 * | - |
| Free-Float |
57.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +11.54% |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Lipman
CEO | Chief Executive Officer | 47 | 02/12/2024 |
Edward Schultz
DFI | Director of Finance/CFO | 42 | 25/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jock Holliman
CHM | Chairman | 73 | 05/04/2006 |
Michael Toporek
CHM | Chairman | 62 | - |
Matthew Lipman
BRD | Director/Board Member | 47 | 14/07/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +11.54% | -.--% | - | - | 31.69L | ||
| 0.00% | -10.09% | +516.49% | +374.19% | 252.01Cr | ||
| +1.72% | +1.63% | +20.40% | +87.91% | 129.68Cr | ||
| +6.92% | -1.61% | -16.67% | +36.97% | 95Cr | ||
| -0.85% | -3.31% | +1.74% | -28.61% | 59Cr | ||
| -0.71% | -14.07% | -17.84% | -3.10% | 42Cr | ||
| 0.00% | -4.37% | +19.58% | +44.03% | 23Cr | ||
| -1.92% | -2.83% | - | - | 19Cr | ||
| +0.45% | +1.35% | +9.63% | -3.23% | 18Cr | ||
| 0.00% | -4.98% | +130.17% | +352.54% | 17Cr | ||
| Average | +1.71% | -5.06% | +82.94% | +107.59% | 72.77Cr | |
| Weighted average by Cap. | +1.18% | -7.59% | +209.82% | +179.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.21Cr 6.31Cr 5.83Cr 5.44Cr 10Cr 681.78Cr 10Cr 70Cr 27Cr 336.34Cr 27Cr 26Cr 1.17TCr | - |
| Net income | 7L 6L 6L 5L 10L 6.5Cr 10L 66.83L 25.8L 3.2Cr 25.8L 25.23L 11Cr | - |
| Net Debt | - | - |
Employees
-
Sector
Construction Materials
















